Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year

被引:30
作者
Cuschieri, Sarah [1 ]
Calleja, Neville [2 ,3 ]
Devleesschauwer, Brecht [4 ,5 ]
Wyper, Grant M. A. [6 ]
机构
[1] Univ Malta, Fac Med & Surg, Dept Anat, Msida, Malta
[2] Univ Malta, Fac Med & Surg, Dept Publ Hlth, Msida, Malta
[3] Minist Hlth, Directorate Hlth Informat & Res, Guardamangia, Malta
[4] Dept Epidemiol & Publ Hlth, Brussels, Belgium
[5] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium
[6] Publ Hlth Scotland, Pl & Wellbeing Directorate, Glasgow, Lanark, Scotland
关键词
Burden of disease; Disability-adjusted life years; DALY; YLD; YLL; Population health; Malta; European burden of disease network; Coronavirus; Covid-19;
D O I
10.1186/s12889-021-11893-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Disability-adjusted life years (DALYs) combine the impact of morbidity and mortality, allowing for comprehensive comparisons of the population. The aim was to estimate the DALYs due to Covid-19 in Malta (March 2020-21) and investigate its impact in relation to other causes of disease at a population level. Methods Mortality and weekly hospital admission data were used to calculate DALYs, based on the European Burden of Disease Network consensus Covid-19 model. Covid-19 infection duration of 14 days was considered. Sensitivity analyses for different morbidity scenarios, including post-acute consequences were presented. Results An estimated 70,421 people were infected (with and without symptoms) by Covid-19 in Malta (March 2020-1), out of which 1636 required hospitalisation and 331 deaths, contributing to 5478 DALYs. These DALYs positioned Covid-19 as the fourth leading cause of disease in Malta. Mortality contributed to 95% of DALYs, while post-acute consequences contributed to 60% of morbidity. Conclusions Covid-19 over 1 year has impacted substantially the population health in Malta. Post-acute consequences are the leading morbidity factors that require urgent targeted action to ensure timely multidisciplinary care. It is recommended that DALY estimations in 2021 and beyond are calculated to assess the impact of vaccine roll-out and emergence of new variants.
引用
收藏
页数:7
相关论文
共 32 条
  • [11] COVID-19 panic, solidarity and equity-the Malta exemplary experience
    Cuschieri, Sarah
    [J]. JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2022, 30 (02): : 459 - 464
  • [12] Valuing the years of life lost due to COVID-19: the differences and pitfalls
    Devleesschauwer, Brecht
    McDonald, Scott A.
    Speybroeck, Niko
    Wyper, Grant M. A.
    [J]. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2020, 65 (06) : 719 - 720
  • [13] Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification
    Fernandez-de-las-Penas, Cesar
    Palacios-Cena, Domingo
    Gomez-Mayordomo, Victor
    Cuadrado, Maria L.
    Florencio, Lidiane L.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (05) : 1 - 9
  • [14] Assessing disability weights based on the responses of 30,660 people from four European countries
    Haagsma, Juanita A.
    de Noordhout, Charline Maertens
    Polinder, Suzanne
    Vos, Theo
    Havelaar, Arie H.
    Cassini, Alessandro
    Devleesschauwer, Brecht
    Kretzschmar, Mirjam E.
    Speybroeck, Niko
    Salomon, Joshua A.
    [J]. POPULATION HEALTH METRICS, 2015, 13
  • [15] Accounting for multimorbidity can affect the estimation of the Burden of Disease: A comparison of approaches
    Hilderink H.B.M.
    Plasmans M.H.D.
    Snijders B.E.P.
    Boshuizen H.C.
    René Poos M.J.J.C.
    van Gool C.H.
    [J]. Archives of Public Health, 74 (1)
  • [16] Huang Yong, 2021, medRxiv, DOI 10.1101/2021.03.03.21252086
  • [17] Institute for Health Metrics and Evaluation (IHME), 2019, REF LIF TABL GHDX GL
  • [18] Institute for Health Metrics and Evaluation (IHME), 2019, I HLTH METR EV IHME
  • [19] Institute for Health Metrics and Evaluation (IHME), 2019, MALT GBD COMP IHME V
  • [20] Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.21203/rs.3.rs-266574/v1, 10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]